UBS Group’s RenovoRx RNXT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $39.5K | Sell |
30,009
-36,723
| -55% | -$48.3K | ﹤0.01% | 6668 |
|
2025
Q1 | $66.1K | Buy |
66,732
+54,466
| +444% | +$53.9K | ﹤0.01% | 6091 |
|
2024
Q4 | $15.8K | Buy |
12,266
+10,030
| +449% | +$12.9K | ﹤0.01% | 6795 |
|
2024
Q3 | $2.37K | Buy |
2,236
+931
| +71% | +$987 | ﹤0.01% | 7232 |
|
2024
Q2 | $1.48K | Buy |
+1,305
| New | +$1.48K | ﹤0.01% | 7406 |
|
2023
Q2 | – | Sell |
-2,530
| Closed | -$8.82K | – | 8311 |
|
2023
Q1 | $8.82K | Buy |
+2,530
| New | +$8.82K | ﹤0.01% | 6598 |
|
2022
Q4 | – | Sell |
-1,256
| Closed | -$3K | – | 9761 |
|
2022
Q3 | $3K | Sell |
1,256
-4,961
| -80% | -$11.9K | ﹤0.01% | 8463 |
|
2022
Q2 | $12K | Buy |
+6,217
| New | +$12K | ﹤0.01% | 6639 |
|
2022
Q1 | – | Sell |
-4,512
| Closed | -$22K | – | 9545 |
|
2021
Q4 | $22K | Buy |
+4,512
| New | +$22K | ﹤0.01% | 6625 |
|